Omega-3 Fatty Acid

Research in HF, omega-3 fatty acids, cardiac imaging among women and drug-eluting stents are among the topics of late-breaking clinical trials being presented at the virtual American Heart Association Scientific Sessions.

Researchers found evidence that COVID-19 may increase the risk for heart failure with preserved ejection fraction, or HFpEF. It was the top story in cardiology last week.

Supplementation with eicosapentaenoic acid and docosahexaenoic acid may reduce the risk for some CVD outcomes, including fatal MI and CHD events, researchers found.

Omega-3 polyunsaturated fatty acids appeared to have a small but significant beneficial effect on perinatal depression, according to results of a meta-analysis published in Journal of Clinical Psychiatry.

Treatment with vitamin D and omega-3 fatty acids supplements for a mean duration of 5.3 years failed to reduce chronic knee pain or improve function or stiffness, according to data published in Arthritis & Rheumatology.

Eating more fish may help women offset the negative effects of air pollution on brain health, according to a study published in Neurology, the medical journal of the American Academy of Neurology.

Dry eye is an increasingly recognized and common condition, and complaints of burning and itchy eyes or impaired vision drive patients to seek relief from their eye care providers.

Adults who regularly took a fish oil supplement experienced lower risk for all-cause and CVD mortality as well as a moderate reduction in CV events, especially in those with hypertension, according to findings published in The BMJ.

In the quest to reduce atherosclerotic CVD, statin therapy has emerged as the gold standard pharmacotherapy.

Healio and Cardiology Today have compiled a list of the most-popular news on heart disease prevention published in 2019.